Your browser doesn't support javascript.
loading
The American Association of Tissue Banks tissue donor screening for Mycobacterium tuberculosis-Recommended criteria and literature review.
Greenwald, Melissa A; Edwards, Noelle; Eastlund, D Ted; Gurevich, Inga; Ho, Andrea Pervine-Zaman; Khalife, Ghada; Lin-Torre, Janet; Thompson, Hannis W; Wilkins, Ross M; Alrabaa, Sally F.
Afiliação
  • Greenwald MA; American Association of Tissue Banks, McLean, Virginia, USA.
  • Edwards N; Uniformed Services University, Bethesda, Maryland, USA.
  • Eastlund DT; Donor Alliance, Denver, Colorado, USA.
  • Gurevich I; LifeNet Health, Virginia Beach, Virginia, USA.
  • Ho AP; University of New Mexico, Albuquerque, New Mexico, USA.
  • Khalife G; AlloSource, Centennial, Colorado, USA.
  • Lin-Torre J; AlloSource, Centennial, Colorado, USA.
  • Thompson HW; Solvita, Dayton, Ohio, USA.
  • Wilkins RM; Wright State University, Dayton, Ohio, USA.
  • Alrabaa SF; MTF Biologics, Edison, New Jersey, USA.
Transpl Infect Dis ; : e14294, 2024 Jun 09.
Article em En | MEDLINE | ID: mdl-38852068
ABSTRACT
After two multistate outbreaks of allograft tissue-transmitted tuberculosis (TB) due to viable bone, evidence-based donor screening criteria were developed to decrease the risk of transmission to recipients. Exclusionary criteria, commentary, and references supporting the criteria are provided, based on literature search and expert opinion. Both exposure and reactivation risk factors were considered, either for absolute exclusion or for exclusion in combination with multiple risk factors. A criteria subset was devised for tissues containing viable cells. Risk factors for consideration included exposure (e.g., geographic birth and residence, travel, homelessness, incarceration, healthcare, and workplace) and reactivation (e.g., kidney disease, liver disease, history of transplantation, immunosuppressive medications, and age). Additional donor considerations include the possibility of sepsis and chronic illness. Donor screening criteria represent minimal criteria for exclusion and do not completely exclude all possible donor TB risks. Additional measures to reduce transmission risk, such as donor and product testing, are discussed but not included in the recommendations. Careful donor evaluation is critical to tissue safety.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article